In “Diagnostic Clinical Genome and Exome Sequencing”, Biesecker et al. are critical of the way doctors have been ordering CGES tests in the past and offer new factors for a doctor to consider before ordering the CGES test. They define the basics of CGES testing and suggest various measures that should be taken prior to placing an order for CGES.
Is the image of exon sequencing clear and necessary? Is the accompanying breakdown useful? Who would understand this information? How else could this information be described to an unfamiliar audience?
